公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
2017 | Glucose transporter 4 promotes head and neck cancer metastasis through TRIM24-DDX58 axis | Chang, YC; Chi, LH; Chang, MW; Su, CY; Lin, YF; Chen, CL; Chen, MH; Chang, PM; Wu, AT; Hsiao, M | Journal of Hematology & Oncology 10(1), 11 | | | |
2017 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients | Yeh, CN; Chang, YC; Su, Y; Hsu, DS; Cheng, CT; Wu, RC; Chung, YH; Chiang, KC; Yeh, TS; Lu, ML; Liu, CY; Chang, PM; Chen, MH; Huang, CY; Hsiao, M ; Chen, MH | Oncotarget 8(69), 113444-113459 | | | |
2020 | Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway | Lai, TC; Fang, CY; Jan, YH; Hsieh, HL; Yang, YF; Liu, CY; Chang, PM; Hsiao, M | Cell Communication and Signaling 18, 164 | | | |
2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 | | | |
2012 | Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer | Yeh, CT; Wu, AT; Chang, PM; Chen, KY; Yang, CN; Yang, SC; Ho, CC; Chen, CC; Kuo, YL; Lee, PY; Liu, YW; Yen, CC; Hsiao, M; Lu, PJ; Lai, JM; Wang, LS; Wu, CH; Chiou, JF; Yang, PC; Huang, CY | Am J Respir Crit Care Med Dec 1;186(11):1180-8 | | | |